WAYS OF MENOPAUSAL HORMONAL THERAPY IN CORRECTION OF METABOLIC DISORDERS AND ANGIOPROTECTION IN POSTMENOPAUSAL WOMEN
Aim. To compare effectiveness of non-drug therapy together with menopausal hormonal therapy (MHT) — estradiol hemihydrate 1 mg/drospirenon 2 mg (Angeliq® Bayer Pharma AG (Germany)) related to normalization of anthropometric and metabolic parameters, elasticity values and vascular age in women with m...
Saved in:
| Main Authors: | V. Yu. Khripaeva, I. N. Barykina, A. S. Salasyuk, V. O. Smirnova, R. V. Palashkin, S. V. Nedogoda |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2016-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Continuous Use of Oral Drospirenone/Estradiol on Lipid Profile, Body Weight, and BP in Females from Early Menopause
by: Roshan Mandloi, et al.
Published: (2025-05-01) -
Modern combined hormonal therapy in early postmenopause women
by: V. B. Mychka, et al.
Published: (2012-08-01) -
Comparative effectiveness of the approaches to correct vascular structural and functional disturbances in postmenopausal women
by: S. N. Tolstov, et al.
Published: (2012-08-01) -
Association between menopause, postmenopausal hormone therapy and peptic ulcer disease in Taiwanese population
by: Kuan-Chih Chen, et al.
Published: (2025-07-01) -
Menopausal hormone therapy affects quality of life in multimorbid late postmenopausal women
by: N. V. Izmozherova, et al.
Published: (2021-11-01)